Keywords: دی هیدروپیریمیدین دهیدروژناز; 5-FU; 5-fluorouracil; BNP; brain natriuretic peptide; CK; creatinine phosphokinases; CK-MB; creatinine phosphokinases-myocardial band; CV; cardiovascular; DYPD; dihydropyrimidine dehydrogenase; ECG; electrocardiography; EF; ejection fraction; FAC; fluoroa
مقالات ISI دی هیدروپیریمیدین دهیدروژناز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دی هیدروپیریمیدین دهیدروژناز; 5-FU; 5-fluorouracil; CEA; carcinoembryonic antigen; CYP3A4; cytochrome 3A4; DPD; dihydropyrimidine dehydrogenase; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; EMA; European Medicines Agency; FDA; Food and Drug Adminis
Keywords: دی هیدروپیریمیدین دهیدروژناز; ADMET; absorption, distribution, metabolism, excretion, toxicity; AHR; aryl hydrocarbon receptor; AUC; area under the curve; BVU; (E)-5-(2-bromovinyl) uracil; CAR; constitutive androstane receptor; cMOAT; Canalicular multispecific organic anion transporte
Keywords: دی هیدروپیریمیدین دهیدروژناز; AIs; aromatase inhibitors; AMPK; Adenosine Monophosphate-Activated Protein Kinase; AR; androgen; ATM; Ataxia Telangiectasia Mutated; ATP; Adenosine Triphosphate; BCSS; breast cancer specific survival; CK-MB; Creatine Kinase-MB; CREB1; cAMP Response Elemen
Keywords: دی هیدروپیریمیدین دهیدروژناز; Capecitabine; 5-Fluorouracil; DPYD; Dihydropyrimidine dehydrogenase; Fluoropyrimidines; Toxicity; Personalized medicine; Pharmacogenetics
Keywords: دی هیدروپیریمیدین دهیدروژناز; ABC transporter; ATP-binding cassette transporter; CAF; cancer-associated fibroblasts; CSCs; cancer stem cells; CTR1; Copper transporter 1; CIMP; CpG island methylator phenotype; CRC; colorectal cancer; DPD; dihydropyrimidine dehydrogenase; ECM; extracell
Keywords: دی هیدروپیریمیدین دهیدروژناز; Fluoropyrimidine drugs; Chemotherapy; Dihydropyrimidine dehydrogenase; HPLC-PDA; Porous graphitic carbon;
Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy
Keywords: دی هیدروپیریمیدین دهیدروژناز; Pharmacogenetics; Toxicity; Colorectal cancer; DPYD; Dihydropyrimidine dehydrogenase; Chemotherapy;
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer
Keywords: دی هیدروپیریمیدین دهیدروژناز; 5â²DFCR; 5â²deoxy-5-fluorocytidine; 5â²DFUR; 5â²-deoxy-5-fluorouridine; 5-FU; 5-fluorouracil; AEs; adverse events; AML; acute promyelocytic leukemia; AU; arbitrary unit; CDA; cytidine deaminase; CES; carboxylesterase; DPD; dihydropyrimidine dehydrogen
Identification of new SNPs associated with severe toxicity to capecitabine
Keywords: دی هیدروپیریمیدین دهیدروژناز; Capecitabine (PubChem CID: 60953); 5-fluorouracil (PubChem CID: 3385); CRC; Colorectal Cancer; ADRs; Adverse Drug Reactions; 5-FU; 5-fluorouracil; HFS; Hand-Foot Syndrome; DPYD; Dihydropyrimidine Dehydrogenase; SNPs; Single Nucleotide Polymorphisms; CDA;
Capecitabine-induced acute toxic leukoencephalopathy
Keywords: دی هیدروپیریمیدین دهیدروژناز; 5-FU; 5-fluorouracil; ADC; apparent diffusion coefficient; DPD; dihydropyrimidine dehydrogenase; DWI; diffusion-weighted imaging; FLAIR; fluid-attenuated inversion recovery; MRI; magnetic resonance imaging; Acute leukoencephalopathy; Toxic; Demyelination;
Development, validation and application of a novel liquid chromatography tandem mass spectrometry assay measuring uracil, 5,6-dihydrouracil, 5-fluorouracil, 5,6-dihydro-5-fluorouracil, α-fluoro-β-ureidopropionic acid and α-fluoro-β-alanine in human pl
Keywords: دی هیدروپیریمیدین دهیدروژناز; U; uracil; UH2; 5,6-dihydrouracil; 5-FU; 5-fluorouracil; FUH2; 5,6-dihydro-5-fluorouracil; FUPA; α-fluoro-β-ureidopropionic acid; FβAL; α-fluoro-β-alanine; DPD; dihydropyrimidine dehydrogenase; DHPase; dihydropyrimidinase; TDM; therapeutic drug monit
Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing
Keywords: دی هیدروپیریمیدین دهیدروژناز; Dihydropyrimidine dehydrogenase; DPYD; 5-Fluorouracil; Capecitabine; Pharmacogenetics; Toxicity;
ClinicalEndogenous plasma and salivary uracil to dihydrouracil ratios and DPYD genotyping as predictors of severe fluoropyrimidine toxicity in patients with gastrointestinal malignancies
Keywords: دی هیدروپیریمیدین دهیدروژناز; Dihydrouracil; Uracil; Dihydropyrimidine dehydrogenase; DPYD; Fluoropyrimidine; Toxicity;
Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial
Keywords: دی هیدروپیریمیدین دهیدروژناز; dihydropyrimidine dehydrogenase; hepatocellular carcinoma; thymidylate synthase
Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
Keywords: دی هیدروپیریمیدین دهیدروژناز; ADH; alcohol dehydrogenase; AKR; aldoketo reductase; ALDH; aldehyde dehydrogenase; CES; carboxylesterase (Ces); DPYD; dihydropyrimidine dehydrogenase; EPHX; epoxide hydrolase; FMO; flavin monooxygenases, Farnesoid X receptor (FXR); NQO; quinone oxidoreduc
Development and validation of a rapid and sensitive UPLC-MS/MS method for determination of uracil and dihydrouracil in human plasma
Keywords: دی هیدروپیریمیدین دهیدروژناز; Uracil; Dihydrouracil; Dihydropyrimidine dehydrogenase; UPLC-MS/MS; Capecitabine; 5-Fluorouracil;
Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time
Keywords: دی هیدروپیریمیدین دهیدروژناز; Dihydropyrimidine dehydrogenase; DPYD; Fluoropyrimidines; Capecitabine; 5-Fluorouracil; Pharmacogenomics; Individualised medicine;
Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: A prospective multi-institutional study in Japan
Keywords: دی هیدروپیریمیدین دهیدروژناز; Uracil-tegafur; Non-small cell lung cancer; Adjuvant chemotherapy; Biomarker; Thymidylate synthase; Dihydropyrimidine dehydrogenase; Orotate phosphoribosyltransferase; Thymidine phosphorylase
Eniluracil Plus 5-Fluorouracil and Leucovorin: Treatment for Metastatic Breast Cancer Patients in Whom Capecitabine Treatment Rapidly Failed
Keywords: دی هیدروپیریمیدین دهیدروژناز; 5-ethynyluracil; 776C85; DPD; Dihydropyrimidine dehydrogenase; Xeloda;
A DPYD Variant (Y186C) Specific to Individuals of African Descent in a Patient With Life-Threatening 5-FU Toxic Effects: Potential for an Individualized Medicine Approach
Keywords: دی هیدروپیریمیدین دهیدروژناز; bp; base pair; 5-FU; 5-fluorouracil; DPD; dihydropyrimidine dehydrogenase; FOLFOX; 5-fluorouracil, leucovorin, oxaliplatin; INR; international normalized ratio; PCR; polymerase chain reaction;
Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro
Keywords: دی هیدروپیریمیدین دهیدروژناز; CRC; colorectal cancer; qRT-PCR; quantitative real time polymerase chain reaction; TS; thymidylate synthase; TP; thymidine phosphorylase; DPD; dihydropyrimidine dehydrogenase; MMR; mismatch repair system; UTR; untranslated regions; NC; nonsense control; m
High Expression of Dihydropyrimidine Dehydrogenase in Lung Adenocarcinoma is Associated With Mutations in Epidermal Growth Factor Receptor: Implications for the Treatment of Non-Small-Cell Lung Cancer Using 5-Fluorouracil
Keywords: دی هیدروپیریمیدین دهیدروژناز; Adenocarcinoma in situ; Dihydropyrimidine dehydrogenase; epidermal growth factor receptor mutation; epidermal growth factor receptor tyrosine kinase inhibitor; S-1;
Effect of protein malnutrition on the metabolism and toxicity of cisplatin, 5-fluorouracil and mitomycin C in rat stomach
Keywords: دی هیدروپیریمیدین دهیدروژناز; APN; aminopeptidase N; ARE; antioxidant response element; BCATm; mitochondrial branched chain aminotransferase; CCBL; cysteine S-conjugate beta-lyase; COX-2; cyclooxygenase-2; CP; cisplatin; CYP; cytochrome P450; DCVC; 1,2-dichlorovinylcysteine; DPD; dihy
The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil
Keywords: دی هیدروپیریمیدین دهیدروژناز; Animal experimentation; Fluorouracil; Dihydropyrimidine dehydrogenase; Drug resistance; Pharmacokinetics; Gimeracil
Pharmacokinetic/Pharmacodynamic Modeling of 5-Fluorouracil by Using a Biomarker to Predict Tumor Growth in a Rat Model of Colorectal Cancer
Keywords: دی هیدروپیریمیدین دهیدروژناز; pharmacokinetics/pharmacodynamic models; cancer chemotherapy; individualized drug therapy; drug metabolizing enzymes; simulations; biomarker; dihydropyrimidine dehydrogenase; anticancer agent;
The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix
Keywords: دی هیدروپیریمیدین دهیدروژناز; Thymidine phosphorylase; Dihydropyrimidine dehydrogenase; Uterine cervical cancer; Chemotherapy; Radiotherapy
Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues
Keywords: دی هیدروپیریمیدین دهیدروژناز; Posttranscriptional and translational control; MicroRNA; Dihydropyrimidine dehydrogenase; 5-FU; Pharmacogenetics; Non-small cell lung cancer;
Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer
Keywords: دی هیدروپیریمیدین دهیدروژناز; Thymidylate synthase; Dihydropyrimidine dehydrogenase; Immunohistochemistry; Non-small cell lung cancer; S-1; Predictive marker
Enhancement of riboflavin production with Bacillus subtilis by expression and site-directed mutagenesis of zwf and gnd gene from Corynebacterium glutamicum
Keywords: دی هیدروپیریمیدین دهیدروژناز; FMN; flavin mononucleotide; FAD; flavin adenine dinucleotide; PPP; pentose phosphate pathway; G6PD; glucose-6-phosphate dehydrogenase; 6GPD; 6-phosphogluconate dehydrogenase; Ru5P; ribulose-5P; FBP; fructose 1,6-bisphosphate; Gra3P; d-glyceraldehyde 3-pho
Validation of an isocratic HPLC method to detect 2-fluoro-β-alanine for the analysis of dihydropyrimidine dehydrogenase activity
Keywords: دی هیدروپیریمیدین دهیدروژناز; Reverse-phase liquid chromatography; Isocratic; Dihydropyrimidine dehydrogenase; Fluoro-β-alanine; Cytosine deaminase
Two cases of 5-fluorouracil toxicity linked with gene variants in the DPYD gene
Keywords: دی هیدروپیریمیدین دهیدروژناز; Dihydropyrimidine dehydrogenase; DPYD; 5-fluorouracil; Toxicity; Colon cancer
Analysis of 5-Fluorouracil–Related Enzymes in Pulmonary Neuroendocrine Carcinoma: Differences in Biological Properties Compared to Epithelial Carcinoma
Keywords: دی هیدروپیریمیدین دهیدروژناز; Dihydropyrimidine dehydrogenase; Large-cell neuroendocrine carcinoma; Laser capture microdissection; Orotate phosphoribosyl transferase; Small-cell lung carcinoma; Thymidylate synthase
The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells
Keywords: دی هیدروپیریمیدین دهیدروژناز; Dihydropyrimidine dehydrogenase; 5-Fluorouracil; Chemotherapy; Head and neck squamous cell carcinoma
Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy
Keywords: دی هیدروپیریمیدین دهیدروژناز; 5-Fluorouracil; Dihydropyrimidine dehydrogenase; Thymidine phosphorylate; Laser capture microdissection; Oral squamous cell carcinomas;
The iscS gene deficiency affects the expression of pyrimidine metabolism genes
Keywords: دی هیدروپیریمیدین دهیدروژناز; Pyrimidine metabolism; Cysteine desulfurase; iscS; Dihydropyrimidine dehydrogenase; Uridine phosphorylase; Cytidine deaminase
Should DPD analysis be required prior to prescribing fluoropyrimidines?
Keywords: دی هیدروپیریمیدین دهیدروژناز; Dihydropyrimidine dehydrogenase; DPYD; 5-Fluorouracil; Pharmacogenetics; Pharmacogenomics; Capecitabine; Chemotherapy; Toxicity;
Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin
Keywords: دی هیدروپیریمیدین دهیدروژناز; Dihydropyrimidine dehydrogenase; 5-Fluorouracil; Toxicity;
Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in adenoid cystic carcinoma of the head and neck: Correlation with clinical outcome
Keywords: دی هیدروپیریمیدین دهیدروژناز; Adenoic cystic carcinoma; Thymidylate synthase; Dihydropyrimidine dehydrogenase; p53; Prognostic factor
FRA1E common fragile site breaks map within a 370 kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD)
Keywords: دی هیدروپیریمیدین دهیدروژناز; Common fragile sites; FRA1E; Dihydropyrimidine dehydrogenase; DPYD; Genomic instability
5-Fluorouracil-related severe toxicity: A comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency
Keywords: دی هیدروپیریمیدین دهیدروژناز; 5-Fluorouracil; Fluoropyrimidines; Dihydropyrimidine dehydrogenase; Deficiency; Toxicity; Single nucleotide polymorphism
The role of Sp1 and Sp3 in the constitutive DPYD gene expression
Keywords: دی هیدروپیریمیدین دهیدروژناز; Sp1; DPYD; Dihydropyrimidine dehydrogenase; Promoter
Thymidylate synthase inhibitors
Keywords: دی هیدروپیریمیدین دهیدروژناز; Thymidylate synthase; Dihydropyrimidine dehydrogenase; Fluoropyrimidines; Capecitabine; Pemetrexed
Prognostic significance of the thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio in invasive cervical cancer
Keywords: دی هیدروپیریمیدین دهیدروژناز; Thymidine phosphorylase; Dihydropyrimidine dehydrogenase; Cervical cancer;
Changes over time in thymidine phosphorylase and dihydropyrimidine dehydrogenase when colon cancer samples are left at room temperature
Keywords: دی هیدروپیریمیدین دهیدروژناز; Colon cancer; Thymidine phosphorylase; Dihydropyrimidine dehydrogenase;
Evaluation of TS-1 based treatment and expression of thymidylate synthase and dihydropyrimidine dehydrogenase on oral squamous cell carcinoma
Keywords: دی هیدروپیریمیدین دهیدروژناز; Oral squamous cell carcinoma; Thymidylate synthase; Dihydropyrimidine dehydrogenase; TS-1; Immunohistochemistry; Chemosensitivity;
The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells
Keywords: دی هیدروپیریمیدین دهیدروژناز; Non-small-cell lung cancer; 5-Fluorouracil; Thymidylate synthase; Dihydropyrimidine dehydrogenase; Thymidine phosphorylases; Orotate phosphoribosyltransferase;
5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice
Keywords: دی هیدروپیریمیدین دهیدروژناز; 5-FU; 5-fluorouracil; DPD; dihydropyrimidine dehydrogenase; 5-FUH2; 5-fluoro-5,6-dihydrouracil; PAS; periodic acid-Schiff; ALT; alanine aminotransferase; AST; aspartate aminotransferase; ip; intraperitoneal; iv; intravenous; AUC; area under the concentrat
Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer-in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase
Keywords: دی هیدروپیریمیدین دهیدروژناز; Thymidylate synthase; Dihydropyrimidine dehydrogenase; 5-Fluorouracil; 5-Chloro-2; 4-Dihydroxypyridine; Non-small cell lung cancer;
Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer
Keywords: دی هیدروپیریمیدین دهیدروژناز; CDDP; cisplatin; DPD; dihydropyrimidine dehydrogenase; EGFR; epidermal growth factor receptor; ERCC1; excision-repair cross-complementing factor 1; GST-Pi; glutathione S-transferase Pi [Ï]; HER2; human epidermal growth factor receptor 2; MAP; mitogen-act